Article
[Preventive contralateral mastectomy despite absence of gene mutation; management and treatment of women with no medical indication].
Nederlands tijdschrift voor geneeskunde - 1 Jan 2017
de Jong L, Klem T M A L, Groen M, Koppert L B, Oldenburg R A, Vrijland W W
Abstract excerpt
Recently, there has been an increase in the rate of contralateral prophylactic mastectomies (CPM) as a therapy for breast cancer. The CPM is performed to achieve a reduction in the risk of developing asecond breast cancer. However, evidence is lacking for beneficial survival outcomes after a CPM in patients without a gene mutation, and complications of surgery are inevitable. Currently there are no evidence-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.